InvestorsHub Logo
Followers 18
Posts 1001
Boards Moderated 0
Alias Born 12/18/2020

Re: None

Tuesday, 03/16/2021 3:28:13 PM

Tuesday, March 16, 2021 3:28:13 PM

Post# of 2447
CSO Harry Zhabilov stated, "As the Company progresses in its efforts to commercialize all the current and yet to be discovered opportunities of its patented treatments, the addition of IMBL and the benefits of obtaining an EMA permit has opened up new and exciting avenues for growth of our Company and the associated potential increase in value to its shareholders."

Sounds familiar?!?!

It was the same spiel he gave when the Merger between Bioclonetics and Enzolytics happened.

https://finance.yahoo.com/news/enzolytics-finalizes-documentation-international-medical-130000414.html

I will have to dig around, but to get European approval doesn't require a European business.